Transglutaminase inhibitor comprising egcg and a method for producing thereof
A technology of transglutaminase and inhibitor, applied in its new application field, can solve the problem of not mentioning transglutaminase inhibitory activity and the like
Inactive Publication Date: 2010-03-31
NAT CANCER CENT
View PDF5 Cites 5 Cited by
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
However, there is no mention in the prior art that EGCG has inhibitory activity on transglutaminase, thereby being used as its inhibitor for the treatment of diseases caused by activation of transglutaminase
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View moreImage
Smart Image Click on the blue labels to locate them in the text.
Smart ImageViewing Examples
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0065] [067] Example 1: In vitro analysis of inhibition of transglutaminase activity
[0066] [068] In order to measure the inhibitory activity of EGCG competing with putrescine, it was observed that [1,4,- 14 C] Transglutaminase-catalyzed reaction between putrescine and succinyl casein.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More PUM
Login to View More Abstract
The present invention relates to a transglutaminase inhibitor comprising epigallocatechin gallate (hereinafter, referred to as EGCG). More particularly, the present invention relates to a transglutaminase inhibitor comprising EGCG which effectively inhibits the activity of transg not lutaminase, the overexpression of which is responsible for the etiology of various diseases, and to novel uses thereof. According to the present invention, provided is a transglutaminase inhibitor and a method of inhibiting transglutaminase, featuring the use of EGCG as an active ingredient. Featuring the use ofEGCG, the novel method of inhibiting transglutaminase according to the present invention is safely applied to patients who suffer from the diseases caused by the overexpression of transglutaminase, thereby obtaining an inhibitory effect against transglutaminase without causing side-effects.
Description
technical field [0001] [001] The present invention relates to transglutaminase inhibitors comprising epigallocatechin gallate (EGCG). More specifically, the present invention relates to a transglutaminase inhibitor comprising EGCG, which effectively inhibits the activity of transglutaminase, whose overexpression is the cause of the etiology of various diseases, and to novel applications thereof . [002] background technology [0002] [003] Transglutaminase is a protective enzyme that is responsible for blood clotting under normal conditions in response to tissue damage. However, these enzymes have also been reported to play important roles in the pathophysiology of various diseases in which the expression levels of these enzymes lack regulation-control (review paper: Soo-Youl Kim: New Target Against Inflammatory Diseases: Transglutaminase 2.Archivum Immunologiae & Therapiae Experimentalis 52, 332-337, 2004). [0003] [004] After the occurrence of various inflammatory disea...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More Application Information
Patent Timeline
Login to View More Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/353
CPCA61K31/353A61P1/04A61P1/18A61P5/00A61P11/00A61P13/08A61P13/10A61P13/12A61P15/00A61P17/00A61P25/00A61P25/14A61P25/16A61P25/28A61P35/00A61P35/02A61P43/00
Inventor 金铢烈郑炅采
Owner NAT CANCER CENT
